p53, bcl-2, and Bax Expression in Renal Cell Carcinoma - immunohistochemical detection of p53 protein versus clinicopathologic parameters

By Vasavada S.P.   Novick A.C.   Williams B.R.G.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 1057-1061

Elsevier

Access to resources Recommend Favorite

Limitations of tissue microarrays in the evaluation of bcl-2 and P53 expression in whole mount derived prostate tissues

By Merseburger A.   Kuczyk M.   Moul J.   Sesterchenn I.   Jonas U.   Srivastava S.   Mostofi E.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 59-59

Elsevier

Access to resources Recommend Favorite

Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer

By Linjawi A.   Kontogiannea M.   Halwani F.   Edwardes M.   Meterissian S.  

Journal of the American College of Surgeons, Vol. 198, Iss. 1, 2004-01 ,pp. : 83-90

Elsevier

Access to resources Recommend Favorite

p53 and HER-2 alterations in renal cell carcinoma

By Zhang X.-H.   Takenaka I.   Sato C.   Sakamoto H.  

Urology, Vol. 50, Iss. 4, 1997-10 ,pp. : 636-642

Elsevier

Access to resources Recommend Favorite

Loss of maspin expression in prostate cancer induced by a P53- and HER-2- pathway/overexpression profiling by whole-mount derived tissue microarrays

By Merseburger A.   Kuczyk M.   David M.   Moul J.   Sesterhenn I.   Jonas U.   Mostofi F.   Srivaslava S.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 61-61

Elsevier

Access to resources Recommend Favorite